MANILA — AC Health, the healthcare arm of the Ayala Group, announced its ambition of becoming a $2-billion healthcare enterprise by 2035—marking a new chapter in its mission to transform health for every Filipino.
Celebrating its 10th anniversary this year, AC Health President & CEO Paolo Borromeo expounded the company’s long-term goals, highlighting a decade of strategic expansion and operational integration across its ecosystem.
“What we’re building is a healthcare group designed for the long haul,” Borromeo said. “We are backed by an ecosystem that is rooted in our commitment to providing quality, accessible healthcare for every Filipino.”
Platform for Nationwide Impact
From its first investment in Generika Drugstore in 2015, AC Health has grown into a robust and integrated network that now includes:
In 2024, AC Health’s revenues grew 10% to ₱9.4 billion. Its provider group under Healthway Medical Network saw a revenue growth of 22%, which was well above the hospital industry growth of 8%. Meanwhile, revenue from its pharma group outperformed the pharma industry, which experienced a 5% decline.
Roadmap to 2035: Growth with Purpose
To achieve its 2035 ambition, AC Health will continue to deepen and expand its presence in key cities through organic and inorganic expansion of its hospital and clinic network. The company will also expand its retail pharma presence nationwide through a multi-brand retail approach.
Key milestones in the next three years include growing its ecosystem to:
“Our goal is to build a healthcare company that is not only financially resilient, but also deeply transformative for Filipinos,” Borromeo said. “In 10 years, we’re going to be a $2-billion healthcare enterprise that serves one in every five Filipinos.”
